Search results
Results From The WOW.Com Content Network
Depression is a major cause of morbidity and mortality worldwide, as the epidemiology has shown. [1] Lifetime prevalence estimates vary widely, from 3% in Japan to 17% in India. Epidemiological data shows higher rates of depression in the Middle East, North Africa, South Asia and the United States than in other regions and countries. [2]
.66 In full remission.65 In partial remission.61 Mild.62 Moderate.63 Severe without psychotic features.64 Severe with psychotic features.60 Unspecified.7 Bipolar I disorder, most recent episode unspecified.0x Bipolar I disorder, single manic episode .06 In full remission.05 In partial remission.01 Mild.02 Moderate
The World Health Organization has published worldwide incidence and prevalence estimates of individual disorders. Obsessive-compulsive disorder is two to three times as common in Latin America, Africa, and Europe as in Asia and Oceania. [7] Schizophrenia appears to be most common in Japan, Oceania, and Southeastern Europe and least common in ...
This article needs to be updated. The reason given is: Many outdated sources and information (older than five years). Please help update this article to reflect recent events or newly available information. (July 2024) Medical condition Major depressive disorder Other names Clinical depression, major depression, unipolar depression, unipolar disorder, recurrent depression Sorrowing Old Man (At ...
The following diagnostic systems and rating scales are used in psychiatry and clinical psychology.This list is by no means exhaustive or complete. For instance, in the category of depression, there are over two dozen depression rating scales that have been developed in the past eighty years.
In much of the world, suicide is stigmatized and condemned for religious or cultural reasons. In some countries, suicidal behavior is a criminal offense punishable by law. Suicide is, therefore, often a secretive act surrounded by taboo and may be unrecognized, misclassified, or deliberately hidden in official records of death.
The source for the data below is the OECD Health Statistics 2018, released by the OECD in June 2018 and updated on 8 November 2018. [1]The unit of measurement used by the OECD is defined daily dose (DDD), defined as "the assumed average maintenance dose per day for a drug used on its main indication in adults". [2]
For those who did achieve full remission, there was a decreased chance of relapse at 12-month (naturalistic) follow-up compared to those patients who only responded. [ 1 ] A reanalysis published in 2023 concluded that STAR*D’s cumulative remission rate was approximately half of that reported.